Structural and functional evolution of human immunodeficiency virus type 1 long terminal repeat CCAAT/enhancer binding protein sites and their use as molecular markers for central nervous system disease progression

Journal of NeuroVirology

Volumn 9, Issue 1, 2003, Pages 55-68

  Hogan, Tricia H ^a   Stauff, Devin L ^a   Krebs, Fred C ^a   Gartner, Suzanne ^b   Quiterio, Shane J ^a   Wigdahl, Brian ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

C EBP; HIV 1; HIVD; LTR; Sequence variation

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN; MOLECULAR MARKER; TRANSCRIPTION FACTOR;

BINDING AFFINITY; BINDING SITE; CENTRAL NERVOUS SYSTEM DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMENTIA; DISEASE COURSE; DISEASE SEVERITY; DNA SEQUENCE; FREQUENCY ANALYSIS; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOPATHOLOGY; LONG TERMINAL REPEAT; MOLECULAR EVOLUTION; MONONUCLEAR CELL; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0037299334     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.1080/13550280390173292     Document Type: Review

References (63)

1. Ait-Khaled M, Emery VC (1994). Phylogenetic relationship between human immunodeficiency virus type 1 (HIV-1) long terminal repeat natural variants present in the lymph node and peripheral blood of three HIV-1-infected individuals. J Gen Virol 75: 1615-1621.
2. Ait-Khaled M, McLaughlin JE, Johnson MA, Emery VC (1995). Distinct HIV-1 long terminal repeat quasispecies present in nervous tissues compared to that in lung, blood and lymphoid tissues of an AIDS patient. AIDS 9: 675-683.
3. Akira S, Isshiki H, Sugita T, Tanabe O, Kinoshita S, Nishio Y, Nakajima T, Hirano T, Kishimoto T (1990). A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. EMBO J 9: 1897-1906.
4. Asjo B, Morfeldt-Manson L, Albert J, Biberfeld G, Karlsson A, Lidman K, Fenyo EM (1986). Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection. Lancet 2: 660-662.
5. Berkhout B, Jeang KT (1992). Functional roles for the TATA promoter and enhancers in basal and Tat-induced expression of the human immunodeficiency virus type 1 long terminal repeat. J Virol 66: 139-149.
6. Birkenmeier EH, Gwynn B, Howard S, Jerry J, Gordon JI, Landschulz WH, McKnight SL (1989). Tissue-specific expression, developmental regulation, and genetic mapping of the gene encoding CCAAT/enhancer binding protein. Genes Dev 3: 1146-1156.
7. Blankson JN, Persaud D, Siliciano RF (2002). The challenge of viral reservoirs in HIV-1 infection. Annu Rev Med 53: 557-593.
8. Bretz JD, Williams SC, Baer M, Johnson PF, Schwartz RC (1994). C/EBP-related protein 2 confers lipopolysaccharide-inducible expression of interleukin 6 and monocyte chemoattractant protein 1 to a lymphoblastic cell line. Proc Natl Acad Sci USA 91: 7306-7310.
9. Bronstein I, Voyta JC, Murphy OJ, Bresnick L, Kricka LJ (1992). Improved chemiluminescent western blotting procedure. Biotechniques 12: 748-753.
10. Burnette WN (1981). "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem 112: 195-203.
11. Chang CJ, Chen TT, Lei HY, Chen DS, Lee SC (1990). Molecular cloning of a transcription factor, AGP/EBP, that belongs to members of the C/EBP family. Mol Cell Biol 10: 6642-6653.
12. Corboy JR, Buzy JM, Zink MC, Clements JE (1992). Expression directed from HIV long terminal repeats in the central nervous system of transgenic mice. Science 258: 1804-1808.
13. Delassus S, Cheynier R, Wain-Hobson S (1991). Evolution of human immunodeficiency virus type 1 nef and long terminal repeat sequences over 4 years in vivo and in vitro. J Virol 65: 225-231.
14. Descombes P, Chojkier M, Lichtsteiner S, Falvey E, Schibler U (1990). LAP, a novel member of the C/EBP gene family, encodes a liver-enriched transcriptional activator protein. Genes Dev 4: 1541-1551.
15. Estable MC, Bell B, Merzouki A, Montaner JS, O'Shaughnessy MV, Sadowski IJ (1996). Human immunodeficiency virus type 1 long terminal repeat variants from 42 patients representing all stages of infection display a wide range of sequence polymorphism and transcription activity. J Virol 70: 4053-4062.
16. Fischer-Smith T, Croul S, Sverstiuk AE, Capini C, L'Heureux D, Regulier EG, Richardson MW, Amini S, Morgello S, Khalili K, Rappaport J (2001). CNS invasion by CD14+/CD16+ peripheral blood-derived monocytes in HIV dementia: perivascular accumulation and reservoir of HIV infection. J NeuroVirol 7: 528-541.
17. Gartner S, Liu Y (2002). Insights into the role of immune activation in HIV neuropathogenesis. J NeuroVirol 8: 69-75.
18. Gartner S, Markovits P, Markovitz DM, Betts RF, Popovic M (1986). Virus isolation from and identification of HTLV-III/LAV-producing cells in brain tissue from a patient with AIDS. JAMA 256: 2365-2371.
19. Gendelman HE, Orenstein JM, Baca LM, Weiser B, Burger H, Kalter DC, Meltzer MS (1989). The macrophage in the persistence and pathogenesis of HIV infection. AIDS 3: 475-495.
20. Gillespie PG, Hudspeth AJ (1991). Chemiluminescence detection of proteins from single cells. Proc Natl Acad Sci USA 88: 2563-2567.
21. Golub EI, Li GG, Volsky DJ (1990). Differences in the basal activity of the long terminal repeat determine different replicative capacities of two closely related human immunodeficiency virus type 1 isolates. J Virol 64: 3654-3660.
22. Goodenow M, Huet T, Saurin W, Kwok S, Sninsky J, Wain-Hobson S (1989). HIV-1 isolates are rapidly evolving quasispecies: evidence for viral mixtures and preferred nucleotide substitutions. J Acquir Immune Defic Syndr 2: 344-352.
23. Gowda SD, Stein BS, Mohagheghpour N, Benike CJ, Engleman EG (1989). Evidence that T cell activation is required for HIV-1 entry in CD4+ lymphocytes. J Immunol 142: 773-780.
24. Henderson AJ, Calame KL (1997). CCAAT/enhancer binding protein (C/EBP) sites are required for HIV-1 replication in primary macrophages but not CD4(+) T cells. Proc Natl Acad Sci USA 94: 8714-8719.
25. Henderson AJ, Connor RI, Calame KL (1996). C/EBP activators are required for HIV-1 replication and proviral induction in monocytic cell lines. Immunity 5: 91-101.
26. Henderson AJ, Zou X, Calame KL (1995). C/EBP proteins activate transcription from the human immunodeficiency virus type 1 long terminal repeat in macrophages/monocytes. J Virol 69: 5337-5344.
27. Hirsch I, Spire B, Tsunetsugu-Yokota Y, Neuveut C, Sire J, Chermann JC (1990). Differences in replication and cytopathogenicity of human immunodeficiency virus type 1 (HIV-1) are not determined by long terminal repeats (LTR). Virology 177: 759-763.
28. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M (1995). Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection [see comments]. Nature 373: 123-126.
29. Hogan TH, Nonnemacher MR, Krebs FC, Henderson A, Wigdahl B (2003). HIV-1 Vpr binding to HIV-1 LTR C/EBP cis-acting elements and adjacent regions is sequence-specific. Biomed Pharmacother In press.
30. Kassa E, Rinke de Wit TF, Hailu E, Girma M, Messele T, Mariam HG, Yohannes S, Jurriaans S, Yeneneh H, Coutinho RA, Fontanet AL (1999). Evaluation of the World Health Organization staging system for HIV infection and disease in Ethiopia: association between clinical stages and laboratory markers. AIDS 13: 381-389.
31. Kirchhoff F, Greenough TC, Hamacher M, Sullivan JL, Desrosiers RC (1997). Activity of human immunodeficiency virus type 1 promoter/TAR regions and tat1 genes derived from individuals with different rates of disease progression. Virology 232: 319-331.
32. Krebs FC, Goodenow MM, Wigdahl B (1997). Neuroglial ATF/CREB factors interact with the human immunodeficiency virus type 1 long terminal repeat. J NeuroVirol 3(Suppl 1): S28-S32.
33. Krebs FC, Hogan TH, Quiterio SJ, Gartner S, Wigdahl B (2001). Lentiviral LTR-directed expression, sequence variation, and disease pathogenesis. In: HIV Sequence Compendium 2001. Kuiken CL, Foley B, Hahn B, Korber B, McCutchan F, Marx PA, Mellors JW, Sodroski J, Wolinksy S (eds). Theoretical Biology and Biophysics Group, Los Alamos National Laboratory: Los Alamos, NM, pp 1-42.
34. Krebs FC, Mehrens D, Pomeroy S, Goodenow MM, Wigdahl B (1998). Human immunodeficiency virus type 1 long terminal repeat quasispecies differ in basal transcription and nuclear factor recruitment in human glial cells and lymphocytes. J Biomed Sci 5: 31-44.
35. Krebs FC, Ross H, McAllister J, Wigdahl B (2000). HIV-1-associated central nervous system dysfunction. Adv Pharmacol 49: 315-385.
36. Lee YH, Williams SC, Baer M, Sterneck E, Gonzalez FJ, Johnson PF (1997). The ability of C/EBP beta but not C/EBP alpha to synergize with an Sp1 protein is specified by the leucine zipper and activation domain. Mol Cell Biol 17: 2038-2047.
37. Levy JA (1993). Pathogenesis of human immunodeficiency virus infection. Microbiol Rev 57: 183-289.
38. Liu Y, Tang XP, McArthur JC, Scott J, Gartner S (2000). Analysis of human immunodeficiency virus type 1 gp160 sequences from a patient with HIV dementia: evidence for monocyte trafficking into brain. J NeuroVirol 6(Suppl 1): S70-S81.
39. Martin JC, Bandres JC (1999). Cells of the monocyte-macrophage lineage and pathogenesis of HIV-1 infection. J Acquir Immune Defic Syndr 22: 413-429.
40. Matsusaka T, Fujikawa K, Nishio Y, Mukaida N, Matsushima K, Kishimoto T, Akira S (1993). Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc Natl Acad Sci USA 90: 10193-10197.
41. McAllister JJ, Phillips D, Millhouse S, Conner J, Hogan T, Ross HL, Wigdahl B (2000). Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication. Virology 274: 262-277.
42. McDougal JS, Mawle A, Cort SP, Nicholson JK, Cross GD, Scheppler-Campbell JA, Hicks D, Sligh J (1985). Cellular tropism of the human retrovirus HTLV-III/LAV. I. Role of T cell activation and expression of the T4 antigen. J Immunol 135: 3151-3162.
43. Michael NL, D'Arcy L, Ehrenberg PK, Redfield RR (1994). Naturally occurring genotypes of the human immunodeficiency virus type 1 long terminal repeat display a wide range of basal and Tat-induced transcriptional activities. J Virol 68: 3163-3174.
44. Naghavi MH, Schwartz S, Sonnerborg A, Vahlne A (1999). Long terminal repeat promoter/enhancer activity of different subtypes of HIV type 1. AIDS Res Hum Retroviruses 15: 1293-1303.
45. Pantaleo G, Graziosi C, Demarest JF, Butini L, Montroni M, Fox CH, Orenstein JM, Kotler DP, Fauci AS (1993). HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease [see comments]. Nature 362: 355-358.
46. Pomerantz RJ, Feinberg MB, Andino R, Baltimore D (1991). The long terminal repeat is not a major determinant of the cellular tropism of human immunodeficiency virus type 1. J Virol 65: 1041-1045.
47. Pope RM, Lentz A, Ness SA (1994). C/EBP beta regulation of the tumor necrosis factor alpha gene. J Clin Invest 94: 1449-1455.
48. Quinones-Mateu ME, Mas A, Lain de Lera T, Soriano V, Alcami J, Lederman MM, Domingo E (1998). LTR and tat variability of HIV-1 isolates from patients with divergent rates of disease progression. Virus Res 57: 11-20.
49. Rodenburg CM, Li Y, Trask SA, Chen Y, Decker J, Robertson DL, Kalish ML, Shaw GM, Allen S, Hahn BH, Gao F (2001). Near full-length clones and reference sequences for subtype C isolates of HIV type 1 from three different continents. AIDS Res Hum Retroviruses 17: 161-168.
50. Ross HL, Gartner S, McArthur JC, Corboy JR, McAllister JJ, Millhouse S, Wigdahl B (2001a). HIV-1 LTR C/EBP binding site sequence configurations preferentially encountered in brain lead to enhanced C/EBP factor binding and increased LTR-specific activity. J NeuroVirol 7: 235-249.
51. Ross HL, Nonnemacher MR, Hogan TH, Quiterio SJ, Henderson A, McAllister JJ, Krebs FC, Wigdahl B (2001b). Interaction between CCAAT/enhancer binding protein and cyclic AMP response element binding protein 1 regulates human immunodeficiency virus type 1 transcription in cells of the monocyte/macrophage lineage. J Virol 75: 1842-1856.
52. Rousseau C, Abrams E, Lee M, Urbano R, King MC (1997). Long terminal repeat and nef gene variants of human immunodeficiency virus type 1 in perinatally infected long-term survivors and rapid progressors. AIDS Res Hum Retroviruses 13: 1611-1623.
53. Sandhu GS, Eckloff BW, Kline BC (1991). Chemiluminescent substrates increase sensitivity of antigen detection in western blots. Biotechniques 11: 14-16.
54. Schuitemaker H, Groenink M, Meyaard L, Kootstra NA, Fouchier RA, Gruters RA, Huisman HG, Tersmette M, Miedema F (1993). Early replication steps but not cell type-specific signalling of the viral long terminal repeat determine HIV-1 monocytotropism. AIDS Res Hum Retroviruses 9: 669-675.
55. Stein B, Baldwin AS, Jr (1993). Distinct mechanisms for regulation of the interleukin-8 gene involve synergism and cooperativity between C/EBP and NF-kappa B. Mol Cell Biol 13: 7191-7198.
56. Tanaka T, Akira S, Yoshida K, Umemoto M, Yoneda Y, Shirafuji N, Fujiwara H, Suematsu S, Yoshida N, Kishimoto T (1995). Targeted disruption of the NF-IL6 gene discloses its essential role in bacteria killing and tumor cytotoxicity by macrophages. Cell 80: 353-361.
57. Tesmer VM, Rajadhyaksha A, Babin J, Bina M (1993). NF-IL6-mediated transcriptional activation of the long terminal repeat of the human immunodeficiency virus type 1. Proc NatL Acad Sci USA 90: 7298-7302.
58. Vallejo M, Ron D, Miller CP, Habener JF (1993). C/ATF, a member of the activating transcription factor family of DNA-binding proteins, dimerizes with CAAT/enhancer-binding proteins and directs their binding to cAMP response elements. Proc Natl Acad Sci USA 90: 4679-4683.
59. Velpandi A, Nagashunmugam T, Otsuka T, Cartas M, Srinivasan A (1992). Structure-function studies of HIV-1: influence of long terminal repeat U3 region sequences on virus production. DNA Cell Biol 11: 369-376.
60. Wei X, Ghosh SK, Taylor ME, Johnson VA, Emini EA, Deutsch P, Lifson JD, Bonhoeffer S, Nowak MA, Hahn BH, et al (1995). Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373: 117-122.
61. Williams KC, Corey S, Westmoreland SV, Pauley D, Knight H, deBakker C, Alvarez X, Lackner AA (2001). Perivascular macrophages are the primary cell type productively infected by simian immunodeficiency virus in the brains of macaques: implications for the neuropathogenesis of AIDS. J Exp Med 193: 905-915.
62. World Health Organization (WHO) (1993). Proposed 'World Health Organization staging system for HIV infection and disease': preliminary testing by an international collaborative cross-sectional study. The WHO International Collaborating Group for the Study of the WHO Staging System. AIDS 7: 711-718.
63. Zhang L, Huang Y, Yuan H, Chen BK, Ip J, Ho DD (1997). Genotypic and phenotypic characterization of long terminal repeat sequences from long-term survivors of human immunodeficiency virus type 1 infection. J Virol 71: 5608-5613.